Medical Marijuana Market in North America and South & Central America report 2028 | Size, Share, Growth by Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America and South & Central America Medical Marijuana Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America and South & Central America Medical Marijuana Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1
5.1.2 Growing acceptance and legalization of medical marijuana for various health conditions and treatments.
5.1.3 Increasing awareness among patients and healthcare providers about the therapeutic benefits of cannabis.
5.1.4 Rising prevalence of chronic diseases and mental health disorders driving demand for alternative therapies.

5.2 Market Opportunities

5.2.1
5.2.2 Development of new medical marijuana formulations and delivery methods tailored to specific patient needs.
5.2.3 Expansion into international markets where medical cannabis regulations are evolving and becoming more favorable.
5.2.4 Opportunities for research and clinical trials to explore additional therapeutic applications of medical marijuana.

5.3 Future Trends

5.3.1
5.3.2 Increasing focus on personalized medicine and targeted therapies using cannabinoid profiles for specific health conditions.
5.3.3 Advancements in cultivation and extraction technologies improving product quality and consistency.
5.3.4 Growing emphasis on education and training for healthcare professionals to ensure informed prescribing and patient care.

5.4 Impact of Drivers and Restraints

6. North America and South & Central America Medical Marijuana Market Regional Analysis

6.1 North America and South & Central America Medical Marijuana Market Overview

6.2 North America and South & Central America Medical Marijuana Market Revenue 2019-2028 (US$ Million)

6.3 North America and South & Central America Medical Marijuana Market Forecast Analysis

7. North America and South & Central America Medical Marijuana Market Analysis – by Product Type

7.1 Beans

7.1.1 Overview
7.1.2 Beans: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Capsules

7.2.1 Overview
7.2.2 Capsules: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Powder and instant coffee

7.3.1 Overview
7.3.2 Powder and instant coffee: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2031 (US$ Million)

8. North America and South & Central America Medical Marijuana Market Analysis – by Category

8.1 Organic

8.1.1 Overview
8.1.2 Organic: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Conventional

8.2.1 Overview
8.2.2 Conventional: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9. North America and South & Central America Medical Marijuana Market Analysis – by Distribution Channel

9.1 Supermarkets and Hypermarkets

9.1.1 Overview
9.1.2 Conventional: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Convenience Stores

9.2.1 Overview
9.2.2 Conventional: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

9.3 Online Retail

9.3.1 Overview
9.3.2 Conventional: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10. North America and South & Central America Medical Marijuana Market – South and Central America Analysis

10.1 North America

10.1.1 North America and South & Central America Medical Marijuana Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 North America and South & Central America Medical Marijuana Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 US: North America and South & Central America Medical Marijuana Market Breakdown, by Product Type
10.1.1.1.2 US: North America and South & Central America Medical Marijuana Market Breakdown, by Category
10.1.1.1.3 US: North America and South & Central America Medical Marijuana Market Breakdown, by Distribution Channel

10.1.1.2 Canada: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Canada: North America and South & Central America Medical Marijuana Market Breakdown, by Product Type
10.1.1.2.2 Canada: North America and South & Central America Medical Marijuana Market Breakdown, by Category
10.1.1.2.3 Canada: North America and South & Central America Medical Marijuana Market Breakdown, by Distribution Channel

10.1.1.3 Mexico : North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Mexico : North America and South & Central America Medical Marijuana Market Breakdown, by Product Type
10.1.1.3.2 Mexico : North America and South & Central America Medical Marijuana Market Breakdown, by Category
10.1.1.3.3 Mexico : North America and South & Central America Medical Marijuana Market Breakdown, by Distribution Channel

10.2 South and Central America

10.2.1 North America and South & Central America Medical Marijuana Market Breakdown, by Key Country, 2022 and 2028 (%)
10.2.1.1 North America and South & Central America Medical Marijuana Market – Revenue and Forecast Analysis – by Country
10.2.1.1 Brazil: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.1.1 Brazil: North America and South & Central America Medical Marijuana Market Breakdown, by Product Type
10.2.1.1.2 Brazil: North America and South & Central America Medical Marijuana Market Breakdown, by Category
10.2.1.1.3 Brazil: North America and South & Central America Medical Marijuana Market Breakdown, by Distribution Channel

10.2.1.2 Argentina: North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.2.1 Argentina: North America and South & Central America Medical Marijuana Market Breakdown, by Product Type
10.2.1.2.2 Argentina: North America and South & Central America Medical Marijuana Market Breakdown, by Category
10.2.1.2.3 Argentina: North America and South & Central America Medical Marijuana Market Breakdown, by Distribution Channel

10.2.1.3 Rest of South and Central America : North America and South & Central America Medical Marijuana Market – Revenue and Forecast to 2028 (US$ Million)

10.2.1.3.1 Rest of South and Central America : North America and South & Central America Medical Marijuana Market Breakdown, by Product Type
10.2.1.3.2 Rest of South and Central America : North America and South & Central America Medical Marijuana Market Breakdown, by Category
10.2.1.3.3 Rest of South and Central America : North America and South & Central America Medical Marijuana Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America and South & Central America Medical Marijuana Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Aphria, Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Aurora Cannabis Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Canopy Growth Corporation

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 CanaQuest Medical Corporation

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 GW Pharmaceuticals

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 The Green Organic Dutchman Holdings

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Cannabis Science, Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 CANVORY

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Organigram Holdings Inc.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Tikun Olam

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights